Season 1 · Episode 4
4. S1 Episode 4: A review of Cabenuva®, an antiretroviral agent for HIV.
The Canadian Breakpoint · Dr. Rupeena Purewal
February 22, 202236m 2s
Audio is streamed directly from the publisher (content.rss.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Dr. Rupeena Purewal invites special guest Saskatoon pharmacist Carley Pozniak to review Cabenuva®, an antiretroviral agent for HIV. Cabenuva® (Cabotegravir Extended Release Injectable Suspension) has been approved in 2020 for medical use in Canada.